Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4176)
All Articles published online
|
Sep 26, 2010 (publication date) through Jul 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stroumpoulis KI, Pantazopoulos IN, Xanthos TT. Hypertrophic cardiomyopathy and sudden cardiac death. World J Cardiol 2010; 2(9): 289-298 [PMID: 21160605 DOI: 10.4330/wjc.v2.i9.289] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v2/i9/289.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Juan A. Vílchez, Diana Hernández-Romero, Francisco Ruiz-Espejo, Antonio Garcia-Honrubia, Mariano Valdés, Pedro Martínez-Hernández, Francisco Marín. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy. Clinical Chemistry and Laboratory Medicine 2011; 49(9) doi: 10.1515/CCLM.2011.642
|
| 3 |
Riya Bhasin, Yazan AlJamal, Hiroto Kitahara, John Blair, Husam H. Balkhy. Robotic unroofing of myocardial bridge of the left anterior descending coronary artery in a patient with hypertrophic obstructive cardiomyopathy and previous septal myectomy. Journal of Cardiology Cases 2024; 29(5): 222 doi: 10.1016/j.jccase.2024.01.001
|
| 4 |
Kelly C. Lear-Kaul. Investigation of Sudden Death in Athletes: The Fittest Bodies in the Morgue. Academic Forensic Pathology 2014; 4(3): 390 doi: 10.23907/2014.049
|
| 5 |
Chao-Yi Chen, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih, Yao-Jen Liang. Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro. Asian Biomedicine 2022; 16(2): 79 doi: 10.2478/abm-2022-0010
|
| 6 |
Meryl Musicante, Hannah H. Kim, Yuanjian Chen, Fang Liao, Syamal K. Bhattacharya, Lu Lu, Yao Sun. Regulation of endothelial nitric oxide synthase in cardiac remodeling. International Journal of Cardiology 2022; 364: 96 doi: 10.1016/j.ijcard.2022.05.013
|
| 7 |
Suman Nag, Sampath K. Gollapudi, Carlos L. del Rio, James A. Spudich, Robert McDowell. Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients. Science Advances 2023; 9(30) doi: 10.1126/sciadv.abo7622
|
| 8 |
Saikat Mitra, Kollengode Ramanathan, Graeme MacLaren. Post-operative management of hypertrophic obstructive cardiomyopathy. Asian Cardiovascular and Thoracic Annals 2022; 30(1): 57 doi: 10.1177/02184923211069189
|
| 9 |
Pieter A. Vriesendorp, Arend F.L. Schinkel, Max Liebregts, Dominic A.M.J. Theuns, Johan van Cleemput, Folkert J. ten Cate, Rik Willems, Michelle Michels. Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology 2015; 8(4): 829 doi: 10.1161/CIRCEP.114.002553
|
| 10 |
U. Bartoszuk, B.W. Keene, M. Baron Toaldo, N. Pereira, N. Summerfield, J. Novo Matos, T.M. Glaus. Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy. The Veterinary Journal 2019; 243: 21 doi: 10.1016/j.tvjl.2018.11.005
|
| 11 |
Alessandra Riccio, Ashley M. Shilling. Unique Medical Considerations for the Athlete Undergoing Anesthesia. Clinics in Sports Medicine 2022; 41(2): 185 doi: 10.1016/j.csm.2021.11.009
|
| 12 |
Yueqin Cai, Jue Tu, Shuizhen Pan, Jianping Jiang, Qiyang Shou, Yun Ling, Yunxiang Chen, Dejun Wang, Weiji Yang, Letian Shan, Minli Chen. Medicinal effect and its JP2/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes. Journal of Ethnopharmacology 2015; 169: 435 doi: 10.1016/j.jep.2015.04.026
|
| 13 |
Nicholas Sheffle, Tracey Bowden. Pre-participation screening for hypertrophic cardiomyopathy in young athletes. British Journal of Cardiac Nursing 2014; 9(11): 551 doi: 10.12968/bjca.2014.9.11.551
|
| 14 |
Brian Cowie. The Preoperative Patient With a Systolic Murmur. Anesthesiology and Pain Medicine 2015; 5(6) doi: 10.5812/aapm.32105
|
| 15 |
Eugene S. Yim, Edward F. Gillis, Krystin Ojala, James MacDonald, Frederick C. Basilico, Gianmichael D. Corrado. Focused Transthoracic Echocardiography by Sports Medicine Physicians. Journal of Ultrasound in Medicine 2013; 32(2): 333 doi: 10.7863/jum.2013.32.2.333
|
| 16 |
Alessandra Riccio, Ashley M. Shilling. Unique Medical Considerations for the Athlete Undergoing Anesthesia. Anesthesiology Clinics 2024; 42(2): 185 doi: 10.1016/j.anclin.2023.11.005
|
| 17 |
Celeste M Murtha, John R Dobson, Anthony B Olinger. A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy. Cureus 2023; doi: 10.7759/cureus.40870
|
| 18 |
Dareuosh Shackebaei, Farid Feizollahi, Mahvash Hesari, Gholamreza Bahrami. The Effect of Diazepam on the Function of Hypertrophied Rats’ Hearts in Ischemia-Reperfusion Conditions. International Cardivascular Research Journal 2016; 10(2): 89 doi: 10.17795/icrj-10(2)89
|
| 19 |
Hussein H. Khachfe, Hamza A. Salhab, Mohamad Y. Fares, Hassan M. Khachfe. Current State of Hypertrophic Cardiomyopathy Clinical Trials. Global Heart 2019; 14(3): 317 doi: 10.1016/j.gheart.2019.07.005
|
| 20 |
K. Savostyanov, A. Pushkov, I. Zhanin, N. Mazanova, S. Trufanov, A. Pakhomov, A. Alexeeva, D. Sladkov, A. Asanov, A. Fisenko. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology. Orphanet Journal of Rare Diseases 2022; 17(1) doi: 10.1186/s13023-022-02319-4
|
| 21 |
S. Marrakchi, I. Kammoun, E. Bennour, L. Laroussi, S. Kachboura. Risk stratification in hypertrophic cardiomyopathy. Herz 2020; 45(1): 50 doi: 10.1007/s00059-018-4700-8
|
| 22 |
Arianne Clare Agdamag, Anders Westanmo, Amy Gravely, Natthapon Angsubhakorn, Lin Yee Chen, Selcuk Adabag. Mortality associated with antiarrhythmic medication for atrial fibrillation among patients with left ventricular hypertrophy. Pacing and Clinical Electrophysiology 2023; 46(7): 738 doi: 10.1111/pace.14711
|
| 23 |
Debasish Das, Debasis Acharya, Tutan Das, Subhas Pramanik. Mega Coronary Arteries with Obstructive Coronary Artery Disease in Hypertrophic Obstructive Cardiomyopathy: A Case Report and Literature Review. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2022; 6(1): 72 doi: 10.4103/jiae.jiae_44_21
|
| 24 |
Grigorios Giamouzis, Apostolos Dimos, Andrew Xanthopoulos, John Skoularigis, Filippos Triposkiadis. Left ventricular hypertrophy and sudden cardiac death. Heart Failure Reviews 2022; 27(2): 711 doi: 10.1007/s10741-021-10134-5
|
| 25 |
Dawn OʼReilly, Laura Beth Enos, Laura Hedlund, Kaylene Hood, Anna Kate Pruett, Daryl Rosenbaum, Reamer L. Bushardt. CME Prescreening of adolescent athletes: How much evaluation is enough?. Journal of the American Academy of Physician Assistants 2012; 25(11): 54 doi: 10.1097/01720610-201211000-00010
|